Fortress Biotech (FBIO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.91, +0.53% vs the prior close of $1.90.
- Volume 219.40K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FBIO rises 0.5% to $1.91. Closed at $1.91, +0.53% vs the prior close of $1.90. Day range $1.88–$1.95, opened at $1.91.
FBIO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — FBIO rises 0.5% to $1.91
- Closed at $1.91, +0.53% vs the prior close of $1.90. Day range $1.88–$1.95, opened at $1.91.
- Volume was 219.40K shares, 0.5x its 50-day average of 403.16K — lighter than usual.
- Price is -23.6% vs its 50-day average ($2.50) and -34.2% vs its 200-day average ($2.90).
- 52-week range $1.88–$4.53; today's close sits at 1% of that range, 57.8% below the 52-week high.
Oct 14, 2026 — FBIO dips 2.6% to $1.90, a 52-week low, 3 down days in a row
- Closed at $1.90, -2.56% vs the prior close of $1.95. Day range $1.88–$1.95, opened at $1.93.
- Volume was 376.10K shares, 0.9x its 50-day average of 415.48K.
- Price is -24.5% vs its 50-day average ($2.52) and -34.7% vs its 200-day average ($2.91).
- 52-week range $1.88–$4.53; today's close sits at 1% of that range, 58.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — FBIO slides 7.6% to $1.95, a 52-week low
- Closed at $1.95, -7.58% vs the prior close of $2.11. Day range $1.93–$2.11, opened at $2.09.
- Volume was 443.50K shares, 1.0x its 50-day average of 452.90K.
- Price is -23.0% vs its 50-day average ($2.53) and -33.2% vs its 200-day average ($2.92).
- 52-week range $1.93–$4.53; today's close sits at 1% of that range, 57.0% below the 52-week high.
Oct 12, 2026 — FBIO dips 1.4% to $2.11
- Closed at $2.11, -1.40% vs the prior close of $2.14. Day range $2.10–$2.13, opened at $2.12.
- Volume was 113.30K shares, 0.2x its 50-day average of 463.49K — lighter than usual.
- Price is -17.2% vs its 50-day average ($2.55) and -28.0% vs its 200-day average ($2.93).
- 52-week range $2.00–$4.53; today's close sits at 4% of that range, 53.4% below the 52-week high.
Oct 9, 2026 — FBIO rises 2.4% to $2.14
- Closed at $2.14, +2.39% vs the prior close of $2.09. Day range $2.09–$2.17, opened at $2.12.
- Volume was 186.20K shares, 0.4x its 50-day average of 469.04K — lighter than usual.
- Price is -16.7% vs its 50-day average ($2.57) and -27.1% vs its 200-day average ($2.94).
- 52-week range $2.00–$4.53; today's close sits at 6% of that range, 52.8% below the 52-week high.
Oct 8, 2026 — FBIO rises 2.5% to $2.09
- Closed at $2.09, +2.45% vs the prior close of $2.04. Day range $2.02–$2.10, opened at $2.03.
- Volume was 265.30K shares, 0.6x its 50-day average of 470.23K — lighter than usual.
- Price is -19.4% vs its 50-day average ($2.59) and -29.0% vs its 200-day average ($2.94).
- 52-week range $2.00–$4.53; today's close sits at 4% of that range, 53.9% below the 52-week high.
Oct 7, 2026 — FBIO dips 0.5% to $2.04
- Closed at $2.04, -0.49% vs the prior close of $2.05. Day range $2.00–$2.06, opened at $2.02.
- Volume was 146.10K shares, 0.3x its 50-day average of 475.36K — lighter than usual.
- Price is -22.1% vs its 50-day average ($2.62) and -30.9% vs its 200-day average ($2.95).
- 52-week range $2.00–$4.53; today's close sits at 2% of that range, 55.0% below the 52-week high.
Oct 6, 2026 — FBIO dips 1.9% to $2.05
- Closed at $2.05, -1.91% vs the prior close of $2.09. Day range $2.02–$2.13, opened at $2.09.
- Volume was 220.00K shares, 0.5x its 50-day average of 479.22K — lighter than usual.
- Price is -22.5% vs its 50-day average ($2.65) and -30.7% vs its 200-day average ($2.96).
- 52-week range $2.00–$4.53; today's close sits at 2% of that range, 54.7% below the 52-week high.
Oct 5, 2026 — FBIO rises 3.0% to $2.09
- Closed at $2.09, +2.96% vs the prior close of $2.03. Day range $2.00–$2.14, opened at $2.03.
- Volume was 553.40K shares, 1.2x its 50-day average of 476.44K.
- Price is -21.7% vs its 50-day average ($2.67) and -29.5% vs its 200-day average ($2.96).
- 52-week range $2.00–$4.53; today's close sits at 4% of that range, 53.9% below the 52-week high.
Oct 2, 2026 — FBIO dips 1.9% to $2.03, a 52-week low, 3 down days in a row
- Closed at $2.03, -1.93% vs the prior close of $2.07. Day range $2.01–$2.09, opened at $2.08.
- Volume was 326.70K shares, 0.7x its 50-day average of 478.82K.
- Price is -24.7% vs its 50-day average ($2.69) and -31.7% vs its 200-day average ($2.97).
- 52-week range $2.01–$4.53; today's close sits at 1% of that range, 55.2% below the 52-week high.
- That makes 3 straight losses.
FBIO latest news & SEC filings
Every SEC filing by or about FBIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jin David received an award of 1,190 shares at $1.82 (≈$2.16K) on Oct 1, 2026; now holds 1,652,761
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $18.72M (prior year $16.41M) (+14.0% vs Jun 30, 2025)
- Net income: -$468.00K (prior year $15.49M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year $0.45) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade FBIO
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 31, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.46% (largest 7.6%).
- Liquidity: about 278.30K shares (≈$531.55K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.91 vs a range of $1.88–$4.53 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 1, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 82.47M shares outstanding (May 7, 2020), +26.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
FBIO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.91 | 1.95 | 1.88 | 1.91 | 219.40K |
| Oct 14, 2026 | 1.93 | 1.95 | 1.88 | 1.90 | 376.10K |
| Oct 13, 2026 | 2.09 | 2.11 | 1.93 | 1.95 | 443.50K |
| Oct 12, 2026 | 2.12 | 2.13 | 2.10 | 2.11 | 113.30K |
| Oct 9, 2026 | 2.12 | 2.17 | 2.09 | 2.14 | 186.20K |
| Oct 8, 2026 | 2.03 | 2.10 | 2.02 | 2.09 | 265.30K |
| Oct 7, 2026 | 2.02 | 2.06 | 2.00 | 2.04 | 146.10K |
| Oct 6, 2026 | 2.09 | 2.13 | 2.02 | 2.05 | 220.00K |
| Oct 5, 2026 | 2.03 | 2.14 | 2.00 | 2.09 | 553.40K |
| Oct 2, 2026 | 2.08 | 2.09 | 2.01 | 2.03 | 326.70K |
| Oct 1, 2026 | 2.17 | 2.17 | 2.07 | 2.07 | 276.90K |
| Sep 30, 2026 | 2.20 | 2.20 | 2.14 | 2.14 | 221.20K |
| Sep 29, 2026 | 2.20 | 2.21 | 2.14 | 2.20 | 257.20K |
| Sep 28, 2026 | 2.26 | 2.27 | 2.17 | 2.17 | 262.80K |
| Sep 25, 2026 | 2.27 | 2.32 | 2.26 | 2.28 | 264.90K |
| Sep 24, 2026 | 2.33 | 2.35 | 2.28 | 2.28 | 203.60K |
| Sep 23, 2026 | 2.45 | 2.45 | 2.33 | 2.34 | 331.80K |
| Sep 22, 2026 | 2.42 | 2.47 | 2.40 | 2.45 | 199.70K |
| Sep 21, 2026 | 2.50 | 2.52 | 2.39 | 2.41 | 283.20K |
| Sep 18, 2026 | 2.50 | 2.57 | 2.47 | 2.51 | 414.70K |
About Fortress Biotech
Fortress Biotech (FBIO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in BAY HARBOR ISLANDS, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1429260.
FBIO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jimmie Harvey | Director | Jan 5, 2026 |
| Malcolm Hoenlein | Director | Jan 5, 2026 |
| Dov Klein | Director | Jan 5, 2026 |
| J Jay Lobell | Director | Jan 5, 2026 |
| Kevin Lorenz | Director | Jan 5, 2026 |
| Lindsay A Md Rosenwald | PRESIDENT, CEO & CHAIRMAN | Mar 20, 2026 |
| Michael S Weiss | Executive Vice Chairman | Mar 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Jin | Chief Financial Officer | Jun 24, 2026 |
| Lindsay A Md Rosenwald | PRESIDENT, CEO & CHAIRMAN | Mar 20, 2026 |
| Michael S Weiss | Executive Vice Chairman | Mar 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
FBIO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $63.26M | $6.82M | -0.07 | $-65.78M |
| Dec 31, 2024 | $57.67M | $-46.00M | -2.69 | $-80.19M |
| Dec 31, 2023 | $84.51M | $-60.64M | -8.47 | $-128.22M |
| Dec 31, 2022 | $75.74M | $-86.58M | -15.97 | $-179.40M |
| Dec 31, 2021 | $68.79M | $-64.70M | -0.79 | $-116.54M |
Latest balance sheet: total assets $316.71M, total liabilities $110.63M, cash $196.58M (as of Jun 30, 2026).
FBIO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $2.98 |
| May 14, 2026 | 8-K Item 2.02 (results) | $2.30 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $2.79 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $2.62 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.96 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.78 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.56 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1.57 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on FBIO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.